➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Harvard Business School
McKinsey
Merck
McKesson
Moodys
Colorcon

Last Updated: January 26, 2021

DrugPatentWatch Database Preview

Litigation Details for GIESECKE & DEVRIENT GMBH v. United States (Fed. Cl. 2017)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

GIESECKE & DEVRIENT GMBH v. United States (Fed. Cl. 2017)

Docket   Start Trial Date Filed 2017-11-17
Court United States Court of Federal Claims Date Terminated
Cause 28:1491 Tucker Act Assigned To Ryan T. Holte
Jury Demand None Referred To
Parties CSRA, INC.; GEMALTO, INC.; GIESECKE & DEVRIENT GMBH; IDEMIA IDENTITY & SECURITY USA, LLC; UNISYS CORPORATION; USA
Patents 10,017,762; 10,080,763; 10,093,934; 10,111,968; 10,151,763; 10,167,486; 10,196,611; 10,251,778; 10,251,934; 10,259,791; 10,287,545; 10,412,941; 10,421,729; 10,421,811; 10,487,126; 10,487,145; 10,501,773; 10,548,903; 10,571,424; 6,110,738; 6,156,372; 6,210,702; 6,251,587; 6,559,305; 6,586,405; 6,629,968; 6,635,274; 6,670,384; 6,755,784; 6,780,228; 6,805,469; 6,869,399; 6,964,635; 7,083,964; 7,117,784; 7,145,780; 7,222,778; 7,223,554; 7,223,584; 7,223,784; 7,241,805; 7,285,702; 7,378,423; 7,378,508; 7,384,738; 7,384,765; 7,396,341; 7,396,644; 7,396,670; 7,396,903; 7,399,903; 7,405,282; 7,455,667; 7,501,455; 7,559,423; 7,611,702; 7,611,724; 7,635,773; 7,670,773; 7,763,451; 7,763,635; 7,763,778; 7,780,635; 7,811,572; 7,811,587; 7,811,773; 7,851,424; 7,931,629; 7,964,202; 7,968,263; 7,968,559; 8,137,729; 8,221,763; 8,221,784; 8,241,670; 8,263,554; 8,287,405; 8,287,590; 8,287,851; 8,287,903; 8,309,572; 8,312,672; 8,372,432; 8,372,968; 8,396,672; 8,399,396; 8,399,445; 8,399,469; 8,399,496; 8,399,508; 8,399,514; 8,445,255; 8,445,486; 8,486,403; 8,486,469; 8,486,898; 8,571,805; 8,586,559; 8,629,111; 8,672,898; 8,729,241; 8,763,222; 8,765,167; 8,765,399; 8,765,421; 8,765,424; 8,778,403; 8,784,408; 8,784,789; 8,784,869; 8,851,372; 8,968,724; 8,968,726; 9,045,729; 9,114,451; 9,126,931; 9,126,941; 9,155,738; 9,155,763; 9,192,571; 9,192,590; 9,211,412; 9,221,765; 9,241,869; 9,241,903; 9,241,931; 9,259,399; 9,259,539; 9,271,931; 9,271,941; 9,271,968; 9,414,784; 9,451,765; 9,486,412; 9,486,424; 9,486,451; 9,486,483; 9,486,584; 9,487,773; 9,539,262; 9,539,341; 9,545,399; 9,549,931; 9,549,941; 9,554,968; 9,586,111; 9,644,196; 9,644,202; 9,670,202; 9,670,262; 9,670,281; 9,724,281; 9,724,378; 9,724,395; 9,724,396; 9,724,405; 9,724,414; 9,726,672; 9,763,941; 9,765,137; 9,765,147; 9,765,208; 9,765,399; 9,773,399; 9,789,156; 9,789,196; 9,789,204; 9,789,210; 9,791,451; 9,869,299; 9,931,305; 9,931,309; 9,931,403; 9,931,414; 9,941,931; 9,964,545; 9,968,115; 9,968,558
Attorneys Barry Clayton McCraw; Edward David Johnson; Goutam Patnaik; Holmes J. Hawkins , lll; Jay Forrest Utley; Marcia G. Madsen; Michael A. Molano; Michel Elias Souaya; Philip Charles Sternhell; Richard Louis Brophy
Firms Baker & McKenzie LLP - Dallas; King & Spalding LLP; Mayer Brown LLP; Mayer Brown LLP NY; Mayer Brown, LLP (DC); Pepper Hamilton LLP (DC); U.S. Department of Justice Civil Division (G), Post
Link to Docket External link to docket
Biologic Drugs cited in GIESECKE & DEVRIENT GMBH v. United States

The biologic drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .

Details for GIESECKE & DEVRIENT GMBH v. United States (Fed. Cl. 2017)

Date Filed Document No. Description Snippet Link To Document
2020-04-29 156 Case 1:17-cv-01812-RTH Document 156 Filed 04/29/20 Page 20 of 24 deterrent in patent suits against…November 2017 1:17-cv-01812 508 Patent None United States Court of Federal Claims … Marine Ins. Co. v. United States, 4 Cl. Ct. 762 (1984) ..........................................…amp; Marine Ins. Co. v. United States, 4 Cl. Ct. 762, 766 (1984). 2 However, “[t]he reverse is not true… Dkt. 147 at 9-10. 2 Case 1:17-cv-01812-RTH Document External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
McKinsey
Moodys
Medtronic
Colorcon
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.